VISX "Wavefront Guided" System has been approved by the FDA

Chicago, IL -- VISX, Inc. announced today that the VISX "wavefront guided" system has been approved by the FDA. Colman R. Kraff, M.D. of the Kraff Eye Institute in Chicago, Illinois, was the principle investigator involved in the FDA trials. Dr. Kraff treated the first patient in the United States for this trial over two years ago.

"This new technology has the potential to provide more accurate and safer results than conventional LASIK surgery, and will have an overall positive effect on patients," said Dr. Colman Kraff. "The VISX "wavefront guided" system creates a unique map of the patient's eye and enables us to do customized treatment."

The Food and Drug Administration authorized the "wavefront guided" system developed by Santa Clara, Calif.- based Visx for correcting nearsightedness and astigmatism. Currently, Dr. Colman Kraff is very instrumental with Visx, conducting human trials of its effectiveness on farsightedness and enhancing the vision of previous LASIK patients.

About Kraff Eye Institute:
The very first excimer laser procedures in the Chicagoland area were performed at the Kraff Eye Institute using the VISX Excimer Laser. The Kraff Eye Institute continues to be the leading U.S. investigative site for all VISX LASIK FDA clinical trials.

Kraff Eye Institute
25 East Washington St., Suite 606, Chicago, IL 60602 | Tel: 312-338-1234
3115 N. Harlem Ave., Suite 300, Chicago, IL 60634 | Tel: 773-777-4444
E-mail: info@kraffeye.com Web: http://www.kraffeye.com

Your Lasik Chicago Specialist